What We Got Right — and Wrong — in ‘Abundance’

What It Covers

One year after publishing *Abundance*, Ezra Klein reunites with co-author Derek Thompson and historian Marc Dunkelman to assess the book's real-world impact. They evaluate housing construction outcomes in California, Texas, and New York, debate corporate power critiques from Elizabeth Warren, examine AI's political complications, and discuss what a future Democratic governing agenda must look like beyond cutting red tape.

Key Questions Answered

• •Vibes vs. Outcomes Gap: Abundance has achieved near-total penetration of Democratic Party discourse — governors Kathy Hochul and JB Pritzker cite supply-side framing, and California passed a bill literally titled the Abundant and Affordable Homes Near Transit Act — but housing starts in California show no measurable increase from 2021 through 2026, exposing a critical gap between legislative momentum and on-the-ground construction results that advocates must urgently address.
• •Texas Housing Model: Dallas absorbed a population equivalent to urban Boston between 2019 and the early 2020s while home prices actually declined, because Texas maintains permitting customs and zoning rules that allow supply to respond to demand. Austin similarly saw average rents fall over 18–24 months after a sustained building surge. These outcomes demonstrate that supply-side housing policy produces measurable rent relief — a stronger outcome than rent freezes alone.
• •Three-Layer Housing Problem: Understanding why housing isn't being built requires separating three distinct timescales: a 50-year accumulation of zoning and permitting rules that restricted supply in blue cities; a 20-year macroeconomic story where post-2008 recession decimated the construction industry, producing the lowest per-capita housing decade on record; and a 5-year financing crisis driven by elevated interest rates post-pandemic. Abundance policy has addressed the first layer but largely ignored the second and third.
• •Abundance Mullet Framework: The most effective Democratic political messaging tested by polling firm Blue Rose combines economic populism with supply-side abundance — framing like "working Americans can't afford the basics because we stopped building them" outperformed either pure populist or pure abundance messaging alone. Politicians like Zohran Mamdani (rent freeze paired with developer fast-tracking) and New Jersey Governor Mikey Sherrill (utility price caps paired with solar permitting reform) embody this synthesis in practice.
• •Corporate Power Blind Spot: Elizabeth Warren's critique — that abundance advocates underemphasize corporate culpability while focusing on government dysfunction — carries partial validity. Klein acknowledges the book was written as a corrective to progressive blind spots, not a comprehensive diagnosis, and that a missing "Chapter 7" would address how concentrated money in politics corrupts the stronger government that abundance requires. Billionaires contributed an estimated 10–25% of 2024 total campaign spending, then received the largest top-0.1% tax cuts in recent history.
• •Speed as Progressive Value: A measurable shift is occurring in Democratic policymaking: Mamdani's Neighborhood Builders Fast Track cuts predevelopment time from 18 months to 10 months, saving up to 2.5 years per affordable housing project. The underlying principle — that delay is not a costless democratic virtue but a corrosive force that prevents government from delivering visible results within election cycles — represents a genuine departure from the procedural-fetish culture that has dominated progressive governance since the 1970s.
• •Operation Warp Speed for GLP-1s: GLP-1 drugs represent the most commercially successful pharmaceutical category in decades, with potential applications in cardiovascular disease, neurodegeneration, and inflammation — yet the federal government has no coordinated strategy to accelerate access. Thompson proposes applying the Operation Warp Speed model: advance market commitments worth hundreds of millions to billions of dollars that allow the government to purchase and distribute GLP-1s at cost, replicating the COVID vaccine distribution infrastructure for a new drug category.